• image
  • image
  • image

AIDS Vaccine 2010

at the Omni Hotel at CNN Center


Late Breaker Abstract Submission

The late breaker abstract submission period is now closed.  Late breaker abstract submissions were accepted from Wednesday, 23 June thru 8:00 AM Eastern on Monday, 2 August 2010.

What is a Late Breaker Abstract?
A late breaker abstract contains novel data, not available at the time of the original abstract submission deadline. Only abstracts meeting this criterion will be accepted for consideration under the category of "Late Breaker." Only those submissions containing the most current, cutting-edge science will be selected. Late breaker abstracts must be submitted via the AIDS Vaccine 2010 abstract submission site by 8:00 AM Eastern on Monday, 2 August 2010 deadline.

Once a late breaker abstract has been accepted and scheduled, it cannot be withdrawn. Authors agree to have the abstract published in Conference materials and as an online open access supplement in AIDS Research and Human Retroviruses.

Late breaker abstract submissions will be accepted from Wednesday, 23 June thru 8:00 AM Eastern on Monday, 2 August 2010 in the following topics: 


  • Acute HIV Infection
  • Adjuvants
  • Animal Models
  • B Cell Immunology and Neutralizing Antibodies
  • B Cell Vaccine Concepts and Design
  • Clinical Trial Site Challenges
  • Host Genetic Factors
  • Immune Escape
  • Innate Immunity
  • Mucosal Immunity
  • Novel Immunogens/Inserts
  • Pediatric/Adolescent Infections & Trials
  • Preclinical & Clinical Therapeutic Trials
  • Preclinical and Clinical Prophylactic Vaccine Trials
  • Prevention Strategies
  • Social/Ethical/Access/Regulatory Issues
  • T Cell Immunity
  • T Cell Vaccine Concepts and Design
  • Vaccine Concepts and Design
  • Viral Diversity
  • Virology & Immunology of HIV Transmission

Online Abstract Submission

  • Abstracts must be submitted via the online submission system on this web site. Submitters will be prompted through the electronic submission process.
  • Click here to view screen shots of the abstract submission site and the information needed for abstract submission.
  • Please carefully review your abstract prior to its submission. You must click "Save and Complete" for the abstract to be submitted.
  • If you do not click "Save and Complete" on the final submission screen, the abstract is considered incomplete and will not be reviewed.
  • Edits to the abstract (other than designating a different category) may be made online after submission up until the deadline of 08:00 AM Eastern, Monday, 2 August 2010.
  • Editing a submitted abstract requires use of the abstract ID number that you will receive by email after you have completed the submission process (see Notification and Correspondence below).
  • You may only have one incomplete abstract at a time. You cannot start a second abstract without completing and submitting the first.

Abstract Formatting

Please do not enter information such as author's names, contact information or abstract titles in all capital letters. Use capital letters only where necessary.

The formatting of abstracts for the abstract book including fonts, font sizes, underlining, bolding etc. will be done electronically by the Conference Organizers. Section headers (Background, Methods, Results, Conclusions) will also be electronically formatted by the Conference Organizers.

Abstract titles are limited to 150 characters. The abstract is limited to 300 words. Please review your abstract submission prior to clicking "save and complete" to verify all information was entered correctly and no text was truncated.

Abstract Selection Process

Abstract submissions will be peer reviewed by the Conference Organizers and members of the Scientific Organizing Committee. To minimize subjectivity in the scoring process, any reviewer with a conflict of interest (as defined by NIH rules, e.g., co-authorship, financial interest, or scientific/personal conflict with the authors that could affect objectivity of scoring) will be excluded from scoring or discussing the abstract in question. In the final rankings, mean score and standard deviation will be calculated, and the reviewers' scores will be anonymous. Abstract acceptance is based upon abstract quality, the potential significance of the observations and the rigor with which the scientific methods were applied. Further, the Conference Organizers consider thematic balance in determining which abstracts will be presented orally.

Acceptance of Abstracts

Compliance with all stated conditions including adherence to the deadline is required. Acknowledgement of receipt of completed abstracts will be sent via email upon submission. Individuals submitting abstracts agree that if their abstract is accepted, they will attend the meeting and present their abstract as scheduled. The presenting author should be able to answer substantive questions about all aspects of their study.

Presenting authors must register no later than Friday, 16 July 2010 for their abstract to be published in the Conference materials and for their presentation to be included in the Conference agenda.

The Organizing Committee reserves the right to decide whether a submission will be accepted, and the right to determine the presentation form. The Organizing Committee will notify authors of acceptance and form of presentation by Wednesday, 23 June 2010.

Publication, Copyright and Webcast Policy

Accepted abstracts will be published in the AIDS Vaccine 2010 Conference materials and as an open access online supplement in AIDS Research and Human Retroviruses.

By submitting an abstract, authors and co-authors transfer any copyrights and grant permission to AIDS Vaccine 2010 to audio/video record oral presentations. A consent release will be signed by the presenter prior to archiving or webcasting the AIDS Vaccine 2010 presentations.

Poster Specifications

Poster presentation space is limited to the dimensions of 47" x 46" (119 cm x 116 cm). Dimensions are listed by width x height. Push pins are the preferred method to adhere your poster to the poster board.

For complete poster presentation guidelines, please click here.